Published in Cancer Weekly, April 19th, 2005
Study 1: Promoter-driven apoptin expression impedes small-cell lung cancer growth.
"Apoptin is derived from chicken anemia virus (CAV) and known to induce tumor specific apoptosis but not in normal cells. The aim of this study was to use increased expression of apoptin by the Myc-Max response element (MMRE) and SV40 enhancer in small-cell lung cancer (SCLC) gene therapy," investigators in South Korea report.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.